Log in to save to my catalogue

Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haemat...

Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haemat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2439261987

Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial

About this item

Full title

Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2020-09, Vol.21 (9), p.1201-1212

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

SummaryBackgroundFindings of retrospective studies suggest that sorafenib maintenance post-transplantation might reduce relapse in patients with FLT3 internal tandem duplication ( FLT3-ITD) acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation. We investigated the efficacy and tolerability of sorafenib maintenance p...

Alternative Titles

Full title

Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2439261987

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2439261987

Other Identifiers

ISSN

1470-2045

E-ISSN

1474-5488

DOI

10.1016/S1470-2045(20)30455-1

How to access this item